Skip to main content
. 2022 Feb 11;13:70. doi: 10.1186/s13287-022-02745-y

Table 5.

The application of ADMSCs in vivo

Year Team Source of stem cells Model Observation time Results
2009 Ganey et al. [73] Canine ADMSCs + HA Canine IDD model 12 months COL II, proteoglycan content ↑, cell density↑
2014 Marfia et al. [64] Human ADMSCs Rat IDD model 12 weeks Biglycan content↑, ACAN gene expression↑, imaging signals in IVD↑
2018 Zhou et al. [74] Human ADMSCs + pig acellular NP scaffold Rabbit IDD model 16 weeks ECM↑, the mechanical properties and biocompatibility of the combination system are brilliant, ADMSCs differentiate into NP cells
2019 Ishiguro et al. [75] Transgenic rat ADMSCs Rat IDD model without NP 6 months Biomechanical properties are maintained in 6 weeks, IVD height maintain, AF and CEPs retain in 6 months
2019 Hua et al. [76] Pretreated human ADMSCs Rat tail IDD model 16 weeks NP-specific markers genes expression and ECM↑, IVD height, water content and ECM content all change

ADMSCs adipose mesenchymal stem cells, ACAN aggrecan, AF annulus fibrosus, CEPs cartilaginous endplates, COL II collagen type II, ECM extracellular matrix, HA hyaluronic acid, IDD intervertebral disc degeneration, IVD intervertebral disc, NP nucleus pulposus